Why the study?
Does preoperative statin dosing affect structural outcomes and retear rates after arthroscopic rotator cuff repair?
Does preoperative statin dosing affect structural outcomes and retear rates after arthroscopic rotator cuff repair?
This editorial highlights the need for robust, prospective studies to determine if statin dosing truly affects structural outcomes after rotator cuff repair, given conflicting evidence in current literature.
Efforts to optimize patients' medical conditions are worthwhile to improve the outcomes of rotator cuff repair (RCR). Investigators in both basic science studies and lower level-of-evidence clinical studies have identified dyslipidemia and statin medication dosing as factors that may affect RCR outcomes. However, a recent retrospective review of a single surgeon's experience indicates that these factors may not significantly affect structural outcomes of RCR. Such discrepancies should compel more robust, prospective efforts to better inform substantive changes in clinical practice.
No takes yet. Share an insight, caveat, or question.
Andrew J. Sheean (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: